Constulose is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Lactulose.
| Product ID | 45963-439_69ea82ba-7151-4284-86b9-8c242fe57fe3 |
| NDC | 45963-439 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Constulose |
| Generic Name | Lactulose |
| Dosage Form | Solution |
| Route of Administration | ORAL |
| Marketing Start Date | 2011-02-28 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA090503 |
| Labeler Name | Actavis Pharma, Inc. |
| Substance Name | LACTULOSE |
| Active Ingredient Strength | 10 g/15mL |
| Pharm Classes | Osmotic Laxative [EPC],Osmotic Activity [MoA],Acidifying Activity [MoA],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2011-02-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA090503 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2011-02-28 |
| Marketing Category | ANDA |
| Application Number | ANDA090503 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2011-02-28 |
| Ingredient | Strength |
|---|---|
| LACTULOSE | 10 g/15mL |
| SPL SET ID: | 461ec39f-eeb4-4460-9b5c-62367d47162b |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 45963-439 | Constulose | Constulose |
| 50090-3436 | Constulose | Constulose |
| 0116-4005 | Lactulose | Lactulose |
| 0121-0577 | LACTULOSE | LACTULOSE |
| 0121-0873 | LACTULOSE | Lactulose |
| 0121-1154 | LACTULOSE | LACTULOSE |
| 0121-1746 | LACTULOSE | LACTULOSE |
| 0121-4577 | LACTULOSE | LACTULOSE |
| 0527-5120 | LACTULOSE | LACTULOSE |
| 0527-5125 | LACTULOSE | LACTULOSE |
| 0603-1378 | Lactulose | lactulose |
| 13668-574 | Lactulose | Lactulose |
| 13668-580 | Lactulose | Lactulose |